OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

COMPANY REGISTRATION NUMBER: NI055010 CHARITY REGISTRATION NUMBER: NIC1000002

Cancer Lifeline

Company Limited by Guarantee Unaudited Financial Statements For the year ended 31 March 2023


Cancer Lifeline

Company Limited by Guarantee

Financial Statements

Year ended 31 March 2023

Examiner’s Report

I report to the trustees on my examination of the financial statements of Cancer Lifeline ('the charity') for the year ended 31 March 2023.

Responsibilities and basis of report

As the trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of Charities Act (Northern Ireland) 2008 (the ‘2008 Act’) and the Companies Act 2006 (‘the 2006 Act’). You are satisfied that the accounts of the company are not required by charity or company law to be audited and have chosen instead to have an independent examination.

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity's financial statements as carried out under section 65 of the 2008 Act. In carrying out my examination I have followed the general Directions given by the Charity Commission for Northern Ireland under section 65(9)(b) of the 2008 Act.

Independent examiner's statement

I confirm that I am qualified to undertake the examination because I am a member of the Chartered Association of Certified Accountants which is one of the listed bodies so qualified.

I have completed my examination. I confirm that no matters have come to my attention in connection with my examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act: or

  2. the financial statements do not accord with those records; or

  3. the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair' view which is not a matter considered as part of an independent examination; or

  4. the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I confirm that there are no other matters to which your attention should be drawn to enable a proper understanding of the accounts to be reached.

Independent Examiner

Ian Murray FCCA, on behalf of Ian Murray & Co.

5[th] September 2023


Cancer Lifeline

Company Limited by Guarantee

Statement of Financial Activities (including income and expenditure account)

Year ended 31 March 2023

2023 2022
Unrestricted Restricted
funds funds Total funds Total funds
Note £ £ £ £
Income and endowments
Donations and legacies 5 59,508 344,015 403,523 392,763
Other trading activities 6 58,631 58,631 57,649
───────── ───────── ───────── ─────────
Total income 118,139 344,015 462,154 450,412
═════════ ═════════ ═════════ ═════════
Expenditure
Expenditure on raising funds:
Costs of other trading activities 7 47,016 47,016 44,362
Expenditure on charitable activities 8,9 70,012 352,452 422,464 403,367
───────── ───────── ───────── ─────────
Total expenditure 117,028 352,452 469,480 447,729
═════════ ═════════ ═════════ ═════════
───────── ───────── ───────── ─────────
Net (expenditure)/income and net
movement in funds 1,111 (8,437) (7,326) 2,683
═════════ ═════════ ═════════ ═════════
Reconciliation of funds
Total funds brought forward 369,176 198,981 568,157 565,474
───────── ───────── ───────── ─────────
Total funds carried forward 370,287 190,544 560,831 568,157
═════════ ═════════ ═════════ ═════════

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

The notes on pages 3 – 11 form part of these Accounts

Page 1

Cancer Lifeline Company Limited by Guarantee Statement of Financial Position 31 March 2023 2023 2022 Note Fixed assets Tangible fixed assels 14 214,581 222,669 Current assets Debtors Cash al bank and in hand 15 900 363,585 359,068 364,485 359,068 Creditors: amounts falling due within one year Net current assets 20 18,235 13,580 345,488 346,250 560,831 Total assets less current liabilities 568,157 Funds of the charity Restricted funds Unrestricted funds 190,544 370,287 198,981 369,176 Total charlty funds 17 560,831 568.157 The notes on pages 3- 11 form part of these Accounls For the year ending 31 March 2023 the charity was entitled lo exemption from audit under section 477 of the Companies Act 2006 relating lo small companies. Directors, responsibilities.. The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial stalemenls. These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies, regime. These financial statements were approved by the board of trustees and authorised for issue on 4th September 2023, and are signed on behalf of the board by.. Bernadetta Mo Trustee tgomery Gloria Malhews Trustee Page 2

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements

Year ended 31 March 2023

1. General information

The charity is a public benefit entity and a private company limited by guarantee, registered in Northern Ireland and a registered charity in Northern Ireland. The address of the registered office is 44 Alliance Avenue, Belfast, BT14 7PJ.

2. Statement of compliance

These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Companies Act 2006.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

There are no material uncertainties about the charity's ability to continue.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Page 3

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

3. Accounting policies (continued)

Incoming resources

All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:

Resources expended.

Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:

All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Page 4

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

3. Accounting policies (continued)

Tangible assets (continued)

An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other recognised gains and losses, unless it reverses a charge for impairment that has previously been recognised as expenditure within the statement of financial activities. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other recognised gains and losses, except to which it offsets any previous revaluation gain, in which case the loss is shown within other recognised gains and losses on the statement of financial activities.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Long leasehold property - 2% straight line
Motor vehicles - 25% reducing balance
Equipment - 20% reducing balance

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the charity are assigned to those units.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as an expense in the period in which it arises.

Page 5

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

4. Limited by guarantee

Cancer Lifeline is a company limited by guarantee and accordingly does not have a share capital.

Every member of the company undertakes to contribute such amount as may be required not exceeding £1 to the assets of the charitable company in the event of its being wound up while he or she is a member, or within one year after he or she ceases to be a member.

5. Donations and legacies

Unrestricted Restricted Total Funds
Funds Funds 2023
£ £ £
Donations
Donations 54,962 54,962
Collection Boxes & Public Collections 4,546 4,546
Grants
DFC (Neighbourhood Renewal) 83,319 83,319
The National Lottery Community Fund [ People in
Communities Programme) 60,915 60,915
HSC [ Public Health Agency] 74,099 74,099
BHSCT [ Carers' Support Services] 10,488 10,488
BHSCT [ Primary Care Talking Therapies] 4,556 4,556
Belfast City Council [Revenue Grant] 18,500 18,500
Belfast City Council Covid-19 Recovery Revitalisation
Fund
Job Retention Scheme Grants
Department for Communities Covid recovery Fund
CFNI The Comic Relief Empower Change Core
Programme 12,320 12,320
CFNI (through Department of Health Cancer Charity
support fund) 66,667 66,667
The National Lottery Community Fund (through the
Dormant Accounts Fund NI) 13,151 13,151
──────── ───────── ─────────
59,508 344,015 403,523
════════ ═════════ ═════════
Unrestricted Restricted Total Funds
Funds Funds 2022
£ £ £
Donations
Donations 37,098 37,098
Collection Boxes & Public Collections 2,472 2,472

Page 6

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

5. Donations and legacies (continued)

Unrestricted Restricted Total Funds
Funds Funds 2022
£ £ £
Grants
DFC (Neighbourhood Renewal) 81,698 81,698
The National Lottery Community Fund [ People in
Communities Programme) 44,997 44,997
HSC [ Public Health Agency] 79,461 79,461
BHSCT [ Carers' Support Services] 10,332 10,332
BHSCT [ Primary Care Talking Therapies] 15,568 15,568
Belfast City Council [Revenue Grant] 18,000 18,000
Belfast City Council Covid-19 Recovery revitalisation
Fund 2,000 2,000
Job Retention Scheme Grants 3,515 3,515
Department for Communities Covid recovery Fund 18,635 18,635
CFNI The Comic Relief Empower Change Core
Programme 12,320 12,320
CFNI (through Department of Health Cancer Charity
Support Fund) 66,667 66,667
The National Lottery Community Fund (through the
Dormant Accounts Fund NI)
──────── ───────── ─────────
39,570 353,193 392,763
════════ ═════════ ═════════
6. Other trading activities
Unrestricted Total Funds Unrestricted Total Funds
Funds 2023 Funds 2022
£ £ £ £
Shop income 58,631 58,631 57,649 57,649
════════ ════════ ════════ ════════
7. Costs of other trading activities
Unrestricted Restricted Total Funds
Funds Funds 2023
£ £ £
Shop costs - wages and salaries 33,793 33,793
Shop costs - rent 697 697
Shop costs - rates & water 479 479
Shop costs - light & heat 2,275 2,275
Shop costs - repairs & maintenance 4,345 4,345
Shop costs - motor vehicle expenses 3,121 3,121
Shop costs - telephone 845 845
Shop costs - miscellaneous 725 725
Shop costs - bank charges 736 736
──────── ──── ────────
47,016 47,016
════════ ════ ════════

Page 7

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

7. Costs of other trading activities (continued)

Unrestricted Restricted Total Funds
Funds Funds 2022
£ £ £
Shop costs - wages and salaries 25,586 10,323 35,909
Shop costs - rent
Shop costs - rates & water
Shop costs - light & heat 322 322
Shop costs - repairs & maintenance 4,207 4,207
Shop costs - motor vehicle expenses 1,161 1,161
Shop costs - telephone 1,411 1,411
Shop costs - miscellaneous 920 920
Shop costs - bank charges 432 432
──────── ──────── ────────
34,039 10,323 44,362
════════ ════════ ════════
Expenditure on charitable activities by fund type
Unrestricted Restricted Total Funds
Funds Funds 2023
£ £ £
Direct Activity 29,896 135,740 165,636
Support costs 40,116 216,712 256,828
──────── ───────── ─────────
70,012 352,452 422,464
════════ ═════════ ═════════
Unrestricted Restricted Total Funds
Funds Funds 2022
£ £ £
Direct Activity 43,268 107,550 150,818
Support costs 42,518 210,031 252,549
──────── ───────── ─────────
85,786 317,581 403,367
════════ ═════════ ═════════
Expenditure on charitable activities by activity type
Activities
undertaken Total funds Total fund
directly Support costs 2023 2022
£ £ £ £
Direct Activity 165,636 253,228 418,864 400,848
Governance costs 3,600 3,600 2,519
───────── ───────── ───────── ─────────
165,636 256,828 422,464 403,367
═════════ ═════════ ═════════ ═════════

8. Expenditure on charitable activities by fund type

9. Expenditure on charitable activities by activity type

Page 8

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

10. Analysis of support costs

Analysis of
support costs
activity 1 Total 2023 Total 2022
£ £ £
Staff costs 206,334 206,334 185,752
Premises 28,433 28,433 36,670
Communications and IT 2,321 2,321 10,986
General office 14,132 14,132 16,073
Finance costs 2,008 2,008 1,445
Governance costs 3,600 3,600 2,520
───────── ───────── ─────────
256,828 256,828 253,446
═════════ ═════════ ═════════

11. Net (expenditure)/income

Net (expenditure)/income is stated after charging/(crediting):

Depreciation of tangible fixed assets

2023 2022
£ £
14,087 11,660
════════ ════════

12. Staff costs

The total staff costs and employee benefits for the reporting period are analysed as follows:

2023 2022
£ £
Wages and salaries 208,355 194,347
Social security costs 12,647 10,769
Employer contributions to pension plans 19,125 16,545
───────── ─────────
240,127 221,661
═════════ ═════════

The average head count of employees during the year was 13 (2022: 12).

No employee received employee benefits of more than £60,000 during the year (2022: Nil).

13. Trustee remuneration and expenses

No Trustee received emoluments during the year (2022: Nil)

The Trustees' received in total £706 (2022: £1,494) in reimbursement of expenses. The reimbursement is made for cost of travelling on Charity business in relation to their duties as Trustees' and also (as with other volunteers) the reimbursement of costs incurred during support visitations.

Page 9

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

14. Tangible fixed assets

Long
leasehold Motor
property vehicles Equipment Total
£ £ £ £
Cost
At 1 April 2022 293,983 11,000 123,381 428,364
Additions 5,999 5,999
───────── ──────── ───────── ─────────
At 31 March 2023 293,983 11,000 129,380 434,363
═════════ ════════ ═════════ ═════════
Depreciation
At 1 April 2022 98,117 5,500 102,078 205,695
Charge for the year 5,880 1,375 6,832 14,087
───────── ──────── ───────── ─────────
At 31 March 2023 103,997 6,875 108,910 219,782
═════════ ════════ ═════════ ═════════
Carrying amount
At 31 March 2023 189,986 4,125 20,470 214,581
═════════ ════════ ═════════ ═════════
At 31 March 2022 195,866 5,500 21,303 222,669
═════════ ════════ ═════════ ═════════
15. Debtors
2023 2022
£ £
Other debtors 900
════ ════

16. Pensions and other post-retirement benefits

Defined contribution plans

The amount recognised in income or expenditure as an expense in relation to defined contribution plans was £19,125 (2022: £16,545).

17. Analysis of charitable funds

Unrestricted funds

At
At 1 Apr 2022 Income Expenditure 31 Mar 2023
£ £ £ £
General funds 145,312 118,139 (117,028) 146,423
Designated Fund 223,864 223,864
───────── ───────── ───────── ─────────
369,176 118,139 (117,028) 370,287
═════════ ═════════ ═════════ ═════════

Page 10

Cancer Lifeline

Company Limited by Guarantee

Notes to the Financial Statements (continued)

Year ended 31 March 2023

17. Analysis of charitable funds (continued)

Purpose of Unrestricted Funds

General Fund - This is an operating fund. These are funds that have been received carrying no restriction on their use and are put to the purposes within the objectives of the Charity at the discretion of the Trustees.

Designated Fund - Its purpose is explained in the Trustees Report (Reserve Policy).

Restricted funds

Restricted funds
At
At 1 Apr 2022 Income Expenditure 31 Mar 2023
£ £ £ £
Restricted Fund(s) - Operating Fund 36,985 344,015 (352,452) 28,548
Restricted - Property Fund 161,996 161,996
───────── ───────── ───────── ─────────
198,981
═════════
344,015
═════════
(352,452)
═════════
190,544
═════════

Purpose of Restricted Funds

Operating Fund(s)- are funds subject to specific trusts, which are declared by the donor(s) are expendable by the trustees in furtherance of some particular aspect(s) of the objects of the charity. These funds are subject to restriction (as to their use) imposed by those from whom the funds are obtained. Resources received but not yet expended at the end of the financial year are retained as a reserve.

The Property Fund - represents the purchase of the Project base (44 Alliance Avenue, Belfast) part of which was funded by a grant of £105,000 from the Department of Social Development and part by Donations.

18. Analysis of net assets between funds

Unrestricted Restricted Total Funds Total Funds
Funds Funds 2023 2022
£ £ £ £
Tangible fixed assets 58,465 156,116 214,581 222,669
Current assets 330,057 34,428 364,485 359,069
Creditors less than 1 year (18,235) (18,235) (13,581)
───────── ───────── ───────── ─────────
Net assets 370,287 190,544 560,831 568,157
═════════ ═════════ ═════════ ═════════

Page 11